WIN 55 212-2 mesylate Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.

Int J Mol Sci. 2020 Jan 25;21(3). pii: E787. doi: 10.3390/ijms21030787. Pietrovito L1, Iozzo M1,…

Freedom WaresJanuary 25, 2020

Canna~Fangled Abstracts

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.

BMC Cancer. 2018 May 23;18(1):583. doi: 10.1186/s12885-018-4496-1. Khan MI1,2, Sobocińska AA3,4, Brodaczewska KK3, Zielniok K5,…

Freedom WaresMay 23, 2018

Canna~Fangled Abstracts

Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia.

Neurosci Lett. 2016 Oct 28;633:87-93. doi: 10.1016/j.neulet.2016.09.020. Epub 2016 Sep 14. Szűcs E1, Dvorácskó S1, Tömböly C1, Büki A2, Kékesi…

Freedom WaresOctober 28, 2016

Canna~Fangled Abstracts

Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.

2015 Jan 12. pii: S0091-3057(15)00005-2. doi: 10.1016/j.pbb.2015.01.003. Florek-Luszczki M1, Wlaz A2, Zagaja M3, Andres-Mach M3, Kondrat-Wrobel MW2, Luszczki JJ4. Author…

Freedom WaresJanuary 12, 2015

Canna~Fangled Abstracts

Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2.

2014 Nov 13;57C:140-145. doi: 10.1016/j.pnpbp.2014.11.005. Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist,…

Freedom WaresNovember 13, 2014

WIN 55 212-2 mesylate

Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.

Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.

Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia.

Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.

Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2.

Recent Posts

Archives

Categories